Dr. Jost Klawitter’s research joined iC42 in 2003 and holds the position of Assistant Professor.  He was awarded a PhD in analytical chemistry and biochemistry by the Universität Bremen, Germany, with highest honors and received the Bruker Best Thesis award.  Dr. Klawitter now holds the rank of Assistant Professor and at iC42 is focused on biomarker discovery and validation. He uses mass spectrometry and NMR-based proteomics and metabolomics approaches for the profiling of small and large molecule biomarkers. 

His special interests are in the development of quantitative highly sensitive (sub pmol/L) targeted biomarker assays in body fluids such as human induced sputum, cerebro-spinal fluid, urine, tissue and plasma. For this he develops and automates assays that utilize innovative sample cleanup followed by multidimensional liquid chromatography mass spectrometry. Dr. Klawitter has planned and performed clinical and analytical studies in collaboration with pharmaceutical industries for several years and has functioned as Chief Technology Officer for Eurofins Medinet Denver from 2007-2009. He is an expert in regulatory compliance and received a Master of Research Quality Assurance (MRQA) by the British Association for Research Quality Assurance in 2007.